SCHEMBL30962894

SCHEMBL30962894

COc1cccc(Cl)c1NC(=O)c1cnc(Cl)nc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 2/20 0.48
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ KEAP1 Q14145 1/20 0.47
▸ NFE2L2 Q16236 1/20 0.47
▸ PTPN11 Q06124 1/20 0.44
▸ PDE4D Q08499 2/20 0.44
▸ PDE4A P27815 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4C Q08493 1/20 0.43
▸ RXFP1 Q9HBX9 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ ATF1 P18846 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ CRHBP P24387 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962730 0.93 POLB (0.46) CHRNA7MEN1KMT2AMAPTKEAP1
SCHEMBL16649261 0.88 PIN1 (0.50) CHRNA7MEN1KMT2AMAPTKEAP1
SCHEMBL30962582 0.87 CHRNA7 (0.41) CHRNA7MEN1KMT2AMAPTKEAP1
SCHEMBL30962627 0.86 PDE4A (0.43) CHRNA7MEN1KMT2AMAPTKEAP1
SCHEMBL30962881 0.85 NFKB1 (0.48) PDE4DPDE4APDE4BPDE4CATF1
SCHEMBL30962815 0.85 CHRNA7 (0.40) CHRNA7MEN1KMT2AMAPTKEAP1
SCHEMBL31612072 0.84 TYRO3 (0.48) CHRNA7MEN1KMT2AMAPTKEAP1
SCHEMBL29076206 0.84 TYRO3 (0.48) CHRNA7MEN1KMT2AMAPTKEAP1
SCHEMBL30962863 0.83 NFKB1 (0.42) MEN1KMT2AMAPTPDE4DPDE4A
SCHEMBL31612059 0.82 LCK (0.46) CHRNA7MEN1KMT2AMAPTKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback